Oncogenic AKAP9-BRAF Fusion Is a Novel Mechanism of MAPK Pathway Activation in Thyroid Cancer
Journal of Clinical Investigation - United States
doi 10.1172/jci23237
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 3, 2005
Authors
Publisher
American Society for Clinical Investigation